Diamond Capital Company logo

Diamond Capital Company

Europe, Geneve, Switzerland, Geneva

Description

Diamond Capital Company offers fixed income, equity, and alternative investment opportunities to clients around the world.

Investor Profile

Diamond Capital Company has backed more than 4 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 3 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series B, Series Unknown, Series D rounds (top funding stages).
  • Majority of deals are located in United States.
  • Strong thematic focus on Health Care, Biotechnology, Medical.

Stage Focus

  • Series B (50%)
  • Series Unknown (25%)
  • Series D (25%)

Country Focus

  • United States (100%)

Industry Focus

  • Health Care
  • Biotechnology
  • Medical
  • Therapeutics
  • Biopharma
  • Operating Systems
  • Real Time
  • Software
  • Pharmaceutical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Diamond Capital Company frequently co-invest with?

SB
Asia, Central Region, Singapore, Singapore
Co-Investments: 1
Domain Associates
North America, California, United States, San Diego
Co-Investments: 1
J.P. Morgan Securities Inc.
North America, New York, United States, New York
Co-Investments: 1
Kleiner Perkins
North America, California, United States, Menlo Park
Co-Investments: 1
Versant Ventures
North America, California, United States, Menlo Park
Co-Investments: 1
Apax Partners
Europe, England, United Kingdom, London
Co-Investments: 1
TPG
North America, California, United States, San Francisco
Co-Investments: 1
HealthCap
Europe, Stockholms Lan, Sweden, Stockholm
Co-Investments: 1
Advanced Technology Ventures
North America, California, United States, Menlo Park
Co-Investments: 1
Wellcome Trust
Europe, England, United Kingdom, London
Co-Investments: 1

What are some of recent deals done by Diamond Capital Company?

Ecrio

Cupertino, California, United States

Ecrio develops a framework to upgrade common applications into communication-rich applications for multiple operating systems and phones.

Operating SystemsReal TimeSoftware
Series BAug 2, 2005
Amount Raised: $3,000,000
Affymax

Cupertino, California, United States

Affymax is a biopharmaceutical company.

BiopharmaBiotechnologyHealth Care
Series DJul 18, 2005
Amount Raised: $60,000,000
Five Prime Therapeutics

San Francisco, California, United States

FivePrime is a clinical-stage biotechnology company that develops treatments for cancers.

BiotechnologyHealth CareMedicalTherapeutics
Series UnknownFeb 8, 2005
Amount Raised: $45,000,000
Acuity Pharmaceuticals

Philadelphia, Pennsylvania, United States

Acuity Pharmaceuticals product-focused ophthalmic pharmaceutical company applying its proprietary technology to the treatment.

Health CareMedicalPharmaceutical
Series BOct 7, 2004
Amount Raised: $15,000,000